|
DNA polymerase inhibitor
|
CHEBI_38234 |
[Any inhibitor of a DNA polymerase.] |
|
EC 2.7.7.* (nucleotidyltransferase) inhibitor
|
CHEBI_76815 |
[An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of any nucleotidyltransferase (EC 2.7.7.*).] |
|
ganglioside
|
CHEBI_28892 |
[A molecule composed of a glycosphingolipid (ceramide and oligosaccharide) with one or more sialic acids linked on the sugar chain.] |
|
ceramide
|
CHEBI_17761 |
[Ceramides (N-acyl-sphingoid bases) are a major subclass of sphingoid base derivatives with an amide-linked fatty acid. The fatty acids are typically saturated or monounsaturated with chain lengths from 14 to 26 carbon atoms; the presence of a hydroxyl group on carbon 2 is fairly common. Ceramides are generally precursors of more complex sphingolipids. In the illustrated generalised structure, R(1) = OH, OX (where X = acyl, glycosyl, phosphate, phosphonate, etc.), or H.] |
|
acidic glycosphingolipid
|
CHEBI_36526 |
|
|
positive regulation of secretory granule organization
|
GO_1904411 |
[Any process that activates or increases the frequency, rate or extent of secretory granule organization.] |
|
regulation of secretory granule organization
|
GO_1904409 |
[Any process that modulates the frequency, rate or extent of secretory granule organization.] |
|
negative regulation of secretory granule organization
|
GO_1904410 |
[Any process that stops, prevents or reduces the frequency, rate or extent of secretory granule organization.] |
|
sebacic acid
|
CHEBI_41865 |
[An alpha,omega-dicarboxylic acid that is the 1,8-dicarboxy derivative of octane.] |
|
alpha,omega-dicarboxylic acid
|
CHEBI_28383 |
|
|
dicarboxylic fatty acid
|
CHEBI_189840 |
[Any fatty acid containing two carboxy groups.] |
|
Clavicular pseudarthrosis
|
HP_0034187 |
[A developmental defect in a the clavicule leading to bending and pathologic fracture, with inability to form a normal bony callus with subsequent fibrous nonunion, leading to the pseudarthrosis (or false joint).] |
|
Midline liver
|
HP_0034188 |
[Position of the liver across the middle of the body instead of being in its normal position to the right of the stomach.] |
|
Anti-thyroid-stimulating hormone receptor antibody positivity
|
HP_0034189 |
[The presence of autoantibodies (immunoglobulins) in the serum that react against thyroid-stimulating hormone.] |
|
Anti-thyroid antibody positivity
|
HP_0430050 |
[The presence of autoantibodies (immunoglobulins) in the blood circulation that react against one or more components on the thyroid.] |
|
Fusion of the caudate and putamen
|
HP_0034180 |
[Abnormal joined appearance of the caudate and putamen with an absence of the anterior limb of the internal capsule.] |
|
Abnormal putamen morphology
|
HP_0031982 |
[Any structural anomaly of the putamen, a brain nucleus which together with the caudate nucleus and fundus striati makes up the striatum.] |
|
Segmental hypoplasia of liver
|
HP_0034182 |
[Anatomically the liver is divided into right and left lobes based on the attachment of its peritoneal ligaments. This term refers to a developmental anomaly characterzied by the underdevelopment of one of the lobes of the liver. This is a rare and usually asymptomatic anomaly that can be detected incidentally on cross sectional imaging with computed tomography or magnetic resonance imaging.] |
|
Spastic triplegia
|
HP_0034183 |
[Spastic weakness found in both lower extremities and one upper extremity.] |
|
Increased insulin like growth factor binding protein acid labile subunit concentration
|
HP_0034184 |
[An abnormally elevated concentration of insulin like growth factor binding protein acid labile subunit level in the blood circulation.] |